GSK releases Avandaryl this month

Published: 2007-03-02 06:59:00

Updated: 2007-03-02 06:59:00

GlaxoSmithKline (GSK) said on March 1 it has launched Avandaryl (rosiglitazone maleate and glimepiride) tablets containing 2 oral antidiabetic drugs used in the management of type 2 diabetes: Rosiglitazone maleate and glimepiride.

Rosiglitazone maleate (Avandia), a member of the thiazolidined...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK